Mai Wealth Advisors Raised Pepsico (PEP) Holding; Minerva Neurosciences (NERV) Shorts Lowered By 1.69%

Mai Wealth Advisors increased Pepsico Inc. (PEP) stake by 4.65% reported in 2017Q3 SEC filing. Mai Wealth Advisors acquired 4,711 shares as Pepsico Inc. (PEP)’s stock rose 5.12%. The Mai Wealth Advisors holds 106,015 shares with $11.81M value, up from 101,304 last quarter. Pepsico Inc. now has $170.50B valuation. The stock increased 0.18% or $0.22 during the last trading session, reaching $119.89. About 4.95M shares traded or 34.58% up from the average. Pepsico, Inc. (NYSE:PEP) has risen 12.20% since January 31, 2017 and is uptrending. It has underperformed by 4.50% the S&P500.

Minerva Neurosciences Incorporated (NASDAQ:NERV) had a decrease of 1.69% in short interest. NERV’s SI was 1.81 million shares in January as released by FINRA. Its down 1.69% from 1.84 million shares previously. With 240,400 avg volume, 8 days are for Minerva Neurosciences Incorporated (NASDAQ:NERV)’s short sellers to cover NERV’s short positions. The SI to Minerva Neurosciences Incorporated’s float is 8.01%. The stock increased 2.46% or $0.15 during the last trading session, reaching $6.25. About 240,494 shares traded or 3.16% up from the average. Minerva Neurosciences, Inc. (NASDAQ:NERV) has risen 56.56% since January 31, 2017 and is uptrending. It has outperformed by 39.86% the S&P500.

Among 21 analysts covering PepsiCo (NYSE:PEP), 8 have Buy rating, 0 Sell and 13 Hold. Therefore 38% are positive. PepsiCo had 63 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Tuesday, August 1 by RBC Capital Markets. Sterne Agee CRT initiated Pepsico, Inc. (NASDAQ:PEP) on Tuesday, July 21 with “Buy” rating. RBC Capital Markets maintained the shares of PEP in report on Friday, May 26 with “Hold” rating. The stock has “Hold” rating by S&P Research on Wednesday, October 7. The rating was maintained by Cowen & Co with “Buy” on Monday, January 8. Stifel Nicolaus maintained Pepsico, Inc. (NASDAQ:PEP) rating on Friday, December 22. Stifel Nicolaus has “Hold” rating and $120.0 target. Jefferies maintained it with “Hold” rating and $113.0 target in Thursday, January 4 report. The stock of Pepsico, Inc. (NASDAQ:PEP) earned “Buy” rating by Jefferies on Tuesday, August 15. Barclays Capital initiated the shares of PEP in report on Monday, January 9 with “Equal Weight” rating. The company was maintained on Friday, March 24 by RBC Capital Markets.

Since August 7, 2017, it had 0 insider purchases, and 2 sales for $7.21 million activity. On Monday, August 7 Gallagher Marie T. sold $4.84M worth of Pepsico, Inc. (NASDAQ:PEP) or 41,489 shares. On Tuesday, October 10 the insider Laguarta Ramon sold $2.37 million.

Investors sentiment increased to 0.94 in 2017 Q3. Its up 0.19, from 0.75 in 2017Q2. It increased, as 51 investors sold PEP shares while 689 reduced holdings. 106 funds opened positions while 593 raised stakes. 964.87 million shares or 1.00% less from 974.57 million shares in 2017Q2 were reported. Janney Montgomery Scott Ltd Limited Liability Company holds 0.45% or 355,337 shares in its portfolio. Chickasaw Mngmt Ltd Llc has 0.02% invested in Pepsico, Inc. (NASDAQ:PEP) for 8,140 shares. Becker Mngmt Incorporated invested in 0.02% or 4,710 shares. Bath Savings Tru, Maine-based fund reported 28,976 shares. Hemenway Com Llc holds 0.21% of its portfolio in Pepsico, Inc. (NASDAQ:PEP) for 8,983 shares. Invesco Ltd reported 2.80 million shares stake. Laurel Grove Capital Ltd Liability Co accumulated 2.23% or 38,530 shares. Weiss Multi, Alabama-based fund reported 28,021 shares. Northwest Inv Counselors Ltd Com holds 29,115 shares or 1.4% of its portfolio. Mitchell Sinkler & Starr Pa reported 12,678 shares. Litman Gregory Asset Mngmt Ltd Liability Corp reported 1,692 shares stake. First Midwest Retail Bank Tru Division stated it has 71,231 shares. Prelude Capital Mgmt holds 0.05% or 4,566 shares in its portfolio. First Manhattan holds 153,878 shares or 0.1% of its portfolio. Robecosam Ag holds 0.5% or 58,515 shares in its portfolio.

Mai Wealth Advisors decreased Spdr S&P Mid Cap 400 Etf (MDY) stake by 1,273 shares to 241,323 valued at $78.75M in 2017Q3. It also reduced Energy Transfer Ptnrs Lp stake by 21,498 shares and now owns 125,730 shares. Unitedhealth Group Inc (Put) (NYSE:UNH) was reduced too.

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. The company has market cap of $241.88 million. The companyÂ’s lead product candidate includes MIN-101, a compound for the treatment of patients with schizophrenia that completed Phase IIb clinical trial. It currently has negative earnings. It also offers MIN-202, which completed Phase IIa clinical trial for treating primary insomnia, as well as completed Phase 1b used for the treatment of major depressive disorder; and MIN-117, a compound that completed Phase IIa clinical trial for the treatment of patients suffering from major depressive disorder.

Among 3 analysts covering Minerva Neurosciences (NASDAQ:NERV), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Minerva Neurosciences had 5 analyst reports since March 9, 2016 according to SRatingsIntel. Jefferies maintained Minerva Neurosciences, Inc. (NASDAQ:NERV) on Friday, May 27 with “Buy” rating. On Wednesday, March 9 the stock rating was maintained by JMP Securities with “Market Outperform”. The company was initiated on Friday, September 1 by Citigroup. Jefferies maintained the shares of NERV in report on Thursday, June 22 with “Buy” rating. Jefferies reinitiated the shares of NERV in report on Thursday, May 12 with “Buy” rating.